Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
Tilde Sciences, a specialty pharmaceutical company, announced that it has acquired two medicines, Daraprim® and Vecamyl® from Vyera Pharmaceuticals.
Tilde Sciences expects a seamless transition from Vyera Pharmaceuticals and uninterrupted access through Optime Care, its specialty pharmacy partner.
read more
Meta Herbal is initiating a recall of Magnum XXL 9800 2000 mg per capsule due to the detection of undeclared sildenafil in the products.
read more
Amneal Pharmaceuticals, Inc. and Strides Pharma Science Limited have jointly announced the introduction of Icosapent ethyl acid soft gel capsules, a product referencing VASCEPA®.
read more
Ogsiveo (nirogacestat) tablets have received approval from the Food and Drug Administration for use in adult patients with progressing desmoid tumors requiring systemic treatment. Marking a milestone, Ogsiveo becomes the inaugural drug sanctioned for addressing desmoid tumors, a rare subset of soft tissue sarcomas.
read more
Pro Doc Limitée has initiated a recall of a specific lot of Donepezil (donepezil hydrochloride) 10 mg tablets, citing concerns that certain bottles may contain oversized tablets. Health Canada is cautioning patients and their caregivers about the potential risks associated with taking an oversized tablet, which could result in receiving up to three...
read more